Drug Design and Discovery in Alzheimer's Disease 2014
DOI: 10.1016/b978-0-12-803959-5.50003-9
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme Inhibitors Involved in the Treatment of Alzheimer’s Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 177 publications
0
7
0
Order By: Relevance
“…The inhibition of key enzymes could alleviate observed symptoms in a variety of pathologies, including Alzheimer’s disease (AD), type 2 diabetes (T2D), obesity, and skin hyperpigmentation [20]. According to the cholinergic hypothesis [21], the approach of inhibiting cholinesterases is widely pursued for the restoration of impaired cholinergic function in AD [22] to improve memory function. Targeting tyrosinase is another frequent strategy thought to be beneficial in the prevention of neuronal degeneration as well as hyperpigmentation problems [23], since the monophenolase activity of this enzyme catalyzes the intermediate conversion of tyrosine in L-DOPA, which is an essential and rate-limiting step in melanin synthesis [24].…”
Section: Introductionmentioning
confidence: 99%
“…The inhibition of key enzymes could alleviate observed symptoms in a variety of pathologies, including Alzheimer’s disease (AD), type 2 diabetes (T2D), obesity, and skin hyperpigmentation [20]. According to the cholinergic hypothesis [21], the approach of inhibiting cholinesterases is widely pursued for the restoration of impaired cholinergic function in AD [22] to improve memory function. Targeting tyrosinase is another frequent strategy thought to be beneficial in the prevention of neuronal degeneration as well as hyperpigmentation problems [23], since the monophenolase activity of this enzyme catalyzes the intermediate conversion of tyrosine in L-DOPA, which is an essential and rate-limiting step in melanin synthesis [24].…”
Section: Introductionmentioning
confidence: 99%
“…Hence, decreased concentration of AChE has been associated with decreased anti‐inflammatory property (Akinyemi et al., 2016). AChE is membrane‐bound and found majorly in the brain, erythrocytes, lymphocytes, and the cholinergic neurons (Revadigar et al, 2014). The main neurotransmitter of the cholinergic system is acetylcholine (ACh), which carries out various functions such as learning, movement control, memory and modulation of cerebral blood flow (Jolitha, Subramanyam, & Devi, 2009).…”
Section: Resultsmentioning
confidence: 99%
“…It is a potent, selective, and well-tolerated reversible inhibitor of AchE. Huperzine A is more selective in the inhibition of AChE than BuChE and also more selective for the G4 form of AchE [ 65 , 66 ].…”
Section: Prominent Role Of Alkaloids In Neuromuscular Junction Diseasesmentioning
confidence: 99%